William Tap

Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors. businesswire.com/news/home/2024…

The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promising efficacy in synovial sarcoma and MRCLS paving the way for T cell therapy in solid tumors. @MSKCancerCenter @MSK_DeptOfMed @MSKSarcoma #fig2" target="_blank" rel="nofollow noopener">sciencedirect.com/science/articl…

Are you attending #ESMOSarcomaAndRareCancers24? Don't miss our excelent Young Oncologists Sessions: 🔸Vesalius talk on managing work-life overload 🔸Clinical case discussion 🔸Mentorship session @WTapMD @DCalleMD @herbloong @OingC1 @myESMO #ESMOAmbassadors

Thrilled to share our latest study in @NatureCancer investigating the diverse malignant and stromal cell states that make up soft tissue #sarcomas (STS) and their associations with patient outcomes and response to treatment! 1/12 nature.com/articles/s4301…

Phase 2 Study: Senescence and the activity of abemaciclib in liposarcoma. bit.ly/3UNEykW

Featured today by @MSKLibrary: A call to action to advance patient-focused and decentralized #clinicaltrials: dx.doi.org/10.1002/cncr.3… @ramyathota1 @SuannaBruinooge @ME_Fleury @ME_Fleury @MRizviMD @WTapMD @TPollastro

We are pleased to welcome Dr. Damon Reed as the inaugural Head of the Division of Pediatric Solid Tumors and as Chief of the Pediatric Sarcoma Service at MSK. His research focuses on characterizing the mechanisms of therapeutic resistance.

@MSKCancerCenter @MSK_DeptOfMed We are hiring a physician scientist w/ focus in GI Oncology.We value academic rigor, innovation, & patient centric approach. Our research programs already helped change practice for countless individuals word-wide. Join us! internaltalent-mskcc.icims.com/jobs/70110/fac…

Featured today by @MSKLibrary: A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma dx.doi.org/10.1158/1078-0… @LXQ_mskcc @karissawhiting @Jason_E_Chan @sujanamovvaMD @BenNacev @AimeeCragoMD @DrErinjeri @WTapMD @sandrapdangelo

The EHE Global Patient Registry is a powerful way for individuals with Epithelioid Hemangioendothelioma and their family members to contribute directly to research that will improve our understanding of EHE. Please join today at: eheregistry.iamrare.org.

Congratulations to gastrointestinal oncologist Dr. @DebSchrag, who received the @ASCO-@AmericanCancer Society Cancer Prevention Award, which recognizes significant contributions to cancer prevention and control research or practice. bit.ly/3CfQykt #ASCO23

Introducing the brand new CTOS Podcast - Interview series, featuring David Thomas, FRACP, PhD. Hosted by Inga-Marie Schaefer, MD and Maureen O’Sullivan,MD. Please download, listen and share. Available on ctos.org! ctos.org/Portals/0/PDF/…

First day came to a close. Great presentations on development of #sarcoma PRO questionnaires on #TGCT @WTapMD & #desmoid by Mrinal Gounder and Anne-Rose Schut & TESS by Jay Wunder. Survivorship data by @OlgaHusson . Grateful to F. Pignatti for coming to reflect on EMA approach.

Inspiring start of 3 days focussed on PROs. Today with a focus on #AYA cancer research & care. Important global perspectives. Delighted to have @WTapMD Vishu Avutu and Marie Barnett from @MSKCancerCenter and @SCSodergren from @unisouthampton in Amsterdam @NKI_nl @avl @OlgaHusson

@DrBetofMDPhD @fumikochino @SprakerMDPhD @DanaFarber Always welcome!

@WTapMD @fumikochino @SprakerMDPhD @DanaFarber Can I come back? 🙏🙏

⁦@DrBetofMDPhD⁩ giving an inspiring talk on exercise oncology at the first annual ⁦@sloan_kettering⁩ and ⁦@DanaFarber⁩ joint #AYA Oncology Research Forum. A wonderful multidisciplinary gathering to advance care for AYA patients with cancer.

Abstract submission is open #ctos2023 Nov 1-4 2023 in Dublin,🇮🇪 ctos.org/Meeting/2023An… Sarcoma of the Year #SRBC Keynotes @janeway_MDRick Haas Global Equity Grants 🌍 Great Debates 📣 Procedural Videos🎦 and more!!! @ashleighg @herbloong maureenosullivan w Pres carolswallow

🚨Today 12.15 - Vesalius talk for young oncologists (and those who feel young) about career in rare cancers! Can’t miss it! Outstanding panel of mentors - @ILugowska @WTapMD @BenWestphalen See you in room B3! @DrLizConnolly @myESMO #ESMOSarcomaandrarecancers23

We are thrilled to welcome Dr. Bob Maki back to the MSK family. Dr. Maki brings long-standing expertise in #sarcoma through innovative research and trials. A dedicated colleague, mentor, friend and a compassionate clinician. Clinics in Manhattan and Nassau campus. Welcome Bob!

@kencardonaMD Congrats Ken, this is amazing news.

Honored and excited to be taking on this role at our new state-of-the-art-oncology center providing inpatient and ambulatory services for our patients.